Kiani Arda, Taghavi Kimia, Rokni-Yazdi Hadi, Abedini Atefeh
Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Chronic Respiratory Diseases Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Tanaffos. 2017 Jun;16(4):304-308.
Pulmonary metastases occasionally do not respond to chemotherapy and surgery. Moreover, some early stage cancer patients, who are candidates for surgery, are unable to tolerate surgery. In such cases, microwave ablation is a convenient alternative for tumor eradication. Microwave ablation has low morbidity and mortality rates compared to traditional cancer treatments. Moreover, the lower procedural cost, potential to perform treatment in an outpatient setting, and repeatability are beneficial aspects of this technique. Herein, we report an adenocarcinoma case that was potentially unsuitable for surgery and was treated with percutaneous microwave pulmonary tumor ablation in August 2015 at the Bronchoscopy and Laser ward of the Shahid Beheshti Medical University, Iran.
肺转移瘤有时对化疗和手术无反应。此外，一些适合手术的早期癌症患者无法耐受手术。在这种情况下，微波消融是一种方便的肿瘤根除替代方法。与传统癌症治疗相比，微波消融的发病率和死亡率较低。此外，该技术的手术成本较低、有可能在门诊进行治疗以及可重复性都是其有益之处。在此，我们报告一例腺癌病例，该病例可能不适合手术，并于2015年8月在伊朗沙希德·贝赫什提医科大学支气管镜与激光病房接受了经皮微波肺肿瘤消融治疗。
